Codice QR

Tezepelumab achieves improvement of severe uncontrolled asthma and rhinosinusitis: Case series

Tezepelumab, a mAb targeting thymic stromal lymphopoietin (TSLP), reduces exacerbations in severe asthma. Four cases in which patients with severe asthma and chronic rhinosinusitis with nasal polyps showed improvements in both conditions after receiving tezepelumab treatment are presented.

Salvato in:
Autori principali: Shigesato Inoue, MD, Hiroaki Ogata, MD, PhD, Yoichi Dotake, MD, Koichi Takagi, MD, PhD, Ayaka Shiota, MD, Yumiko Ishii, MD, PhD, Kentaro Tanaka, MD, PhD, Keiko Kan-o, MD, PhD, Hiromasa Inoue, MD, PhD
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2025-05-01
Serie:Journal of Allergy and Clinical Immunology: Global
Soggetti:
Asthma control
tezepelumab
rhinosinusitis
severe asthma
nasal polyps
Accesso online:http://www.sciencedirect.com/science/article/pii/S2772829325000499
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi